Semaglutide in non-diabetic obese Chinese patients with acute coronary syndrome: a multicenter retrospective study
{{output}}
Objective: This study aimed to assess clinical benefits of semaglutide for East Asian non-diabetic obese patients with ACS who have undergone percutaneous coronary intervention (PCI) . ... ...
